Sandoz Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
as on 12-07-2024
- Paid Up Capital ₹ 3.20 Cr
as on 12-07-2024
- Company Age 29 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 133.00 Cr
as on 12-07-2024
- Revenue 0.39%
(FY 2022)
- Profit 21.05%
(FY 2022)
- Ebitda 52.00%
(FY 2022)
- Net Worth 9.54%
(FY 2022)
- Total Assets 23.53%
(FY 2022)
About Sandoz
The Corporate was formerly known as Sandoz Pharma (India) Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 3.20 Cr.
The company has closed loans amounting to ₹133.00 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Monaz Noble, Sudhir Bhandare, and Vandana Singh serve as directors at the Company.
- CIN/LLPIN
U24230MH1995PTC086989
- Company No.
086989
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Mar 1995
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Sandoz?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Monaz Noble  | Director | Current | |
| Sudhir Bhandare | Director | 05-Dec-2018 | Current |
| Vandana Singh | Additional Director | Current |
Financial Performance and Corporate Structure Insights of Sandoz.
Sandoz Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 0.39% increase. The company also saw a substantial improvement in profitability, with a 21.05% increase in profit. The company's net worth moved up by a moderate rise of 9.54%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sandoz?
In 2022, Sandoz had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Standard Chartered Bank Creation Date: 27 Jun 2003 | ₹108.00 Cr | Satisfied |
Banque National De Paris Creation Date: 06 Dec 1999 | ₹5.00 Cr | Satisfied |
Union Bank Of India Creation Date: 19 Mar 1999 | ₹10.00 Cr | Satisfied |
How Many Employees Work at Sandoz?
Sandoz has a workforce of 1661 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sandoz, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sandoz's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
